Lans Holdings Inc (fka LAHO)

[ApollyonZ]

$LAHO..Nikon will accept 4 billion yen of series 2 unsecured convertible bonds with stock acquisition rights through a third-party allocation by Healios, and expand the business partnership. Nikon, as Healios' main partner, will advance Healios' development of practical applications for regenerative medicine. Nikon will contribute to this effort towards the practical use of regenerative medicine in Japan and to the improvement of QOL (quality of life) of people by leveraging the know-how and technologies of both companies.

https://www.nikon.com/news/2019/0710_01.htm

..Jul. 10--Frank Poucher, a retired Air Force colonel from California, insists that the two stem cell treatments he has received for his Stage 4 congestive heart failure helped him regain his quality of life. "If it wasn't a miracle, it was a remarkable improvement," the 79-year-old said in an interview. Many physicians, scientists, and regulators from the U.S. Food and Drug Administration would disagree, saying there's no proof stem cell treatments work as marketed for any of a wide variety of conditions.

..Since the order, 94 letters have been sent to the federal court overseeing the case in Miami, according to the case file accessible through the court's online filing system. Five letters were added to the file prior to June 25..Letter writers include Josephine Spataro, of Danville, Calif., who wrote that two stem cell treatments left one of her knees "free of pain and completely functional" compared to her other knee "which is still somewhat painful" three years after a conventional knee replacement.

https://www.bloomberg.com/research/stocks/news/article.asp?docKey=600-201907100001KRTRIB__BUSNEWS_31415_6701-1&ex=true&ticker=SPPI

..Global Stem Cells Group Plans Bone Marrow Clinical Trials For Knee Osteoarthritis

..According to the Centers for Disease Control (CDC), knee osteoarthritis will affect 67 million people in the United States by 2030.

https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/


Once-twice per week a $38-$40M regenerative deal.


$LAHO GSCG